BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30518482)

  • 21. Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue.
    Amraiz D; Zaidi NU; Fatima M
    Enzyme Microb Technol; 2016 Oct; 92():26-30. PubMed ID: 27542741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arthropod EVs mediate dengue virus transmission through interaction with a tetraspanin domain containing glycoprotein Tsp29Fb.
    Vora A; Zhou W; Londono-Renteria B; Woodson M; Sherman MB; Colpitts TM; Neelakanta G; Sultana H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6604-E6613. PubMed ID: 29946031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
    Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
    Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.
    Madhvi A; Hingane S; Srivastav R; Joshi N; Subramani C; Muthumohan R; Khasa R; Varshney S; Kalia M; Vrati S; Surjit M; Ranjith-Kumar CT
    Sci Rep; 2017 Jul; 7(1):5816. PubMed ID: 28725041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti‑dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression.
    Bryan-Marrugo OL; Arellanos-Soto D; Rojas-Martinez A; Barrera-Saldaña H; Ramos-Jimenez J; Vidaltamayo R; Rivas-Estilla AM
    Mol Med Rep; 2016 Sep; 14(3):2155-63. PubMed ID: 27431377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of ST081006 against the dengue virus.
    Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH
    Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral action of nitric oxide on dengue virus type 2 replication.
    Takhampunya R; Padmanabhan R; Ubol S
    J Gen Virol; 2006 Oct; 87(Pt 10):3003-3011. PubMed ID: 16963759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
    Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
    Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antiviral activity of bromocriptine against dengue virus replication.
    Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
    Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells.
    Manchala NR; Dungdung R; Trivedi P; Unniyampurath U; Pilankatta R
    Microb Pathog; 2019 Dec; 137():103762. PubMed ID: 31560972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of protein kinase C promotes dengue virus replication.
    Noppakunmongkolchai W; Poyomtip T; Jittawuttipoka T; Luplertlop N; Sakuntabhai A; Chimnaronk S; Jirawatnotai S; Tohtong R
    Virol J; 2016 Mar; 13():35. PubMed ID: 26931565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
    Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
    Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, discovery and SAR of the fused tricyclic derivatives of indoline and imidazolidinone against DENV replication and infection.
    Qian W; Xue JX; Xu J; Li F; Zhou GF; Wang F; Luo RH; Liu J; Zheng YT; Zhou GC
    Bioorg Chem; 2022 Mar; 120():105639. PubMed ID: 35093691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference of dengue replication by blocking the access of 3' SL RNA to the viral RNA-dependent RNA polymerase.
    Tunghirun C; Narkthong V; Chaicumpa W; Chimnaronk S
    Antiviral Res; 2020 Oct; 182():104921. PubMed ID: 32835694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
    Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
    J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
    Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
    Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honeysuckle aqueous extract and induced let-7a suppress dengue virus type 2 replication and pathogenesis.
    Lee YR; Yeh SF; Ruan XM; Zhang H; Hsu SD; Huang HD; Hsieh CC; Lin YS; Yeh TM; Liu HS; Gan DD
    J Ethnopharmacol; 2017 Feb; 198():109-121. PubMed ID: 28052239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening.
    Niyomrattanakit P; Wan KF; Chung KY; Abas SN; Seh CC; Dong H; Lim CC; Chao AT; Lee CB; Nilar S; Lescar J; Shi PY; Beer D; Lim SP
    Antiviral Res; 2015 Jul; 119():36-46. PubMed ID: 25896272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.